참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Methanesulfonic Acid | HCID 6395 | — |
| 반응물 | Eprosartan | HCID 5281037 | — |
| 용매 | Acetic Acid | HCID 176 | — |
| 생성물 | Eprosartan Mesylate | HCID 5282474 | — |
반응 단계
An embodiment of the present invention is as follows: eprosartan is dissolved or suspended in glacial acetic acid, then methanesulfonic acid is added and stirred to obtain a solution of eprosartan mesylate in glacial acetic acid, the precipitated solid is stirred and filtered to obtain a solid of eprosartan mesylate, or glaicial acetic acid is concentrated to dry to obtain a solid of eprosartan mesylate, or an organic ester solvent is added dropwise to the glacial acetic acid under stirring to precipitate crystal and separate to obtain a solid of eprosartan mesylate, wherein the ratio of eprosartan (mass, g): methanesulfonic acid (mass, g): glacial acetic acid (volume, ml) is 1:0.1-5.0:1-15, and the temperature of reaction is 10° C.-110° C.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US08546585B2 |
|---|
| 출처 데이터셋 | uspto-grants-2013_10 |
|---|
| ORD ID | ord-92fcf26e3c7047f6bae52ea452360d6e |
|---|
| 출처 메모 | uspto-grants-2013_10 |
|---|